Tag Archives: vaccine for COVID-19

Frontline workers are among those who will receive the Covid vaccine first (Representational) New Delhi: Around 50,000 doctors from the CAPF (central armed police force) will be among those who will receive the first round of Covid vaccines early next year under the supervision of the Ministry of the Interior. …

NEW DELHI: India, the world’s largest vaccine maker, is expected to launch its first vaccines in the coming weeks with at least three candidates under active consideration by India’s drug regulator. The Pune-based Serum Institute of India and Hyderabad-based pharmaceutical company Bharat Biotech have already approached the Controller General of …

Serum Institute will manufacture Covishield and other formulation from Novavax Inc. (Representative) Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-COVID-19 formulations as the world’s largest vaccine producer prepares for a massive response to the coronavirus pandemic. India, which has been hit hard by the …

New Delhi: As the UK begins vaccinating people with Pfizer’s coronavirus vaccine, a huge concern has emerged that has called into question the safety of vaccines. According to regulators from the United States Food and Drug Administration (FDA), four volunteers who received the vaccine injections during the testing phase developed …

By: PTI | London | December 9, 2020 8:43:41 pm An anaphylactoid reaction tends to involve a skin rash, shortness of breath, and sometimes a drop in blood pressure, and both NHS workers who experienced this are said to have a history of severe allergies and carry adrenaline pens with …

NEW DELHI: A committee of experts from the Central Drug Standard Control Organization (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates from Serum Institute and Bharat Biotech, after deliberating on their applications to obtain an emergency use authorization for injections. official sources said. The request …

With safety and efficacy data, Covaxin will be available in the first quarter of 2020, he said. (Archive) Hyderabad: Covaxin, a vaccine for COVID-19, will be available in the first quarter of next year, said Suchitra Ella, joint managing director of Bharat Biotech on Wednesday. “With the safety and efficacy …

The panel reviewed the applications of Pfizer, Serum Institute and Bharat Biotech (Representational) New Delhi: Proposals from the Serum Institute and Bharat Biotech for the use of emergency vaccines have not been approved because of inadequate safety and efficacy data, sources said Wednesday. “Both proposals are not approved due to …

The Oxford-Astra data will be analyzed around the world and many countries will have the vaccine. On the day Britain began immunizing its population with a Covid-19 injection developed by Germany’s BioNTech SE and US-based Pfizer Inc., a peer-reviewed study of the UK’s own-produced vaccine left some key questions unanswered. …

The government is pinning its hopes for a massive supply of vaccines to the Serum Institute. (Figurative) Bangalore: The Serum Institute of India, the world’s largest producer of vaccines by volume, is close to signing a supply contract with the Center and will likely set prices at Rs 250 ($ …